Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy
Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a...
Gespeichert in:
Veröffentlicht in: | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-07, Vol.16 (4), p.615-620 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 620 |
---|---|
container_issue | 4 |
container_start_page | 615 |
container_title | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] |
container_volume | 16 |
creator | Ishida, Jun Toyama, Hirochika Matsumoto, Ippei Asari, Sadaki Goto, Tadahiro Terai, Sachio Nanno, Yoshihide Yamashita, Azusa Mizumoto, Takuya Ueda, Yuki Kido, Masahiro Ajiki, Tetsuo Fukumoto, Takumi Ku, Yonson |
description | Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection. |
doi_str_mv | 10.1016/j.pan.2016.05.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1807078956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1424390316300527</els_id><sourcerecordid>4131151651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxi0EoqXwAFyQJS5cNoztOH9AqoQqoEiVOBTOlmPPUi-Js9hJpX0zHo8Ju12kCvXkOfzmG8_3DWMvBRQCRPV2U2xtLCSVBegCQD1ip6KU5Uq1Qjw-1qBO2LOcNwBSCtE-ZSeylqqGtj1lv6_RjdHzbQqDTTtOgi6hnYLjfnaT7bmzyYU4DpaHyKcb5AmHaON0h2Zu1xOmYye6aRx2fD2mh8Te8cvw44a7eZh7Am6R1F3wGB0NIBFSnbjmO7Tp_wOesydr22d8cXjP2PdPH79dXK6uvn7-cvHhauU0yGnVVM6islhrX6MH0Xnyo1OibruuqsFL2fhWQeUkNpUovZfE2qrVZaO1KK06Y2_2uts0_poxT2YI2WHf24jjnI1ooIa6aXVF6Ot76GacU6Tf_aUoDK0kUWJPuTTmnHBtDt4bAWaJ1WwMrWqWWA1oQ7FSz6uD8twN6I8ddzkS8H4PIFlxGzCZ7MJipg-J_DJ-DA_Kn9_rdn2Iwdn-J-4w_9vCZGnAXC93tZyVqBSAlrX6A8VZyyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1807424532</pqid></control><display><type>article</type><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</creator><creatorcontrib>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</creatorcontrib><description>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</description><identifier>ISSN: 1424-3903</identifier><identifier>EISSN: 1424-3911</identifier><identifier>DOI: 10.1016/j.pan.2016.05.003</identifier><identifier>PMID: 27237099</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cancer ; Cancer therapies ; Carcinoma, Pancreatic Ductal - epidemiology ; Carcinoma, Pancreatic Ductal - pathology ; Carcinoma, Pancreatic Ductal - surgery ; Cellular biology ; Chemotherapy ; Disease ; Endocrinology & Metabolism ; Endoscopy ; Female ; Funding ; Gastroenterology and Hepatology ; Humans ; Incidence ; Kaplan-Meier Estimate ; Lymphatic system ; Male ; Medical prognosis ; Metachronous ; Metastasis ; Middle Aged ; Mutation ; Neoplasm Recurrence, Local - epidemiology ; Neoplasms, Second Primary - epidemiology ; Neoplasms, Second Primary - pathology ; Neoplasms, Second Primary - surgery ; Pancreas ; Pancreas - diagnostic imaging ; Pancreas - pathology ; Pancreatectomy ; Pancreatic ductal carcinoma ; Pancreatic Neoplasms - epidemiology ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - surgery ; Pathology ; Patients ; Remnant pancreatic cancer ; Second primary ; Sensors ; Studies ; Surgery ; Survival Analysis ; Tomography, X-Ray Computed ; Treatment outcome ; Tumors</subject><ispartof>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-07, Vol.16 (4), p.615-620</ispartof><rights>IAP and EPC</rights><rights>2016 IAP and EPC</rights><rights>Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul/Aug 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</citedby><cites>FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</cites><orcidid>0000-0001-8704-4353 ; 0000-0002-8665-2776</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27237099$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishida, Jun</creatorcontrib><creatorcontrib>Toyama, Hirochika</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Asari, Sadaki</creatorcontrib><creatorcontrib>Goto, Tadahiro</creatorcontrib><creatorcontrib>Terai, Sachio</creatorcontrib><creatorcontrib>Nanno, Yoshihide</creatorcontrib><creatorcontrib>Yamashita, Azusa</creatorcontrib><creatorcontrib>Mizumoto, Takuya</creatorcontrib><creatorcontrib>Ueda, Yuki</creatorcontrib><creatorcontrib>Kido, Masahiro</creatorcontrib><creatorcontrib>Ajiki, Tetsuo</creatorcontrib><creatorcontrib>Fukumoto, Takumi</creatorcontrib><creatorcontrib>Ku, Yonson</creatorcontrib><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><title>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</title><addtitle>Pancreatology</addtitle><description>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma, Pancreatic Ductal - epidemiology</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Carcinoma, Pancreatic Ductal - surgery</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Disease</subject><subject>Endocrinology & Metabolism</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Funding</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metachronous</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasms, Second Primary - epidemiology</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Neoplasms, Second Primary - surgery</subject><subject>Pancreas</subject><subject>Pancreas - diagnostic imaging</subject><subject>Pancreas - pathology</subject><subject>Pancreatectomy</subject><subject>Pancreatic ductal carcinoma</subject><subject>Pancreatic Neoplasms - epidemiology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Pathology</subject><subject>Patients</subject><subject>Remnant pancreatic cancer</subject><subject>Second primary</subject><subject>Sensors</subject><subject>Studies</subject><subject>Surgery</subject><subject>Survival Analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment outcome</subject><subject>Tumors</subject><issn>1424-3903</issn><issn>1424-3911</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks9u1DAQxi0EoqXwAFyQJS5cNoztOH9AqoQqoEiVOBTOlmPPUi-Js9hJpX0zHo8Ju12kCvXkOfzmG8_3DWMvBRQCRPV2U2xtLCSVBegCQD1ip6KU5Uq1Qjw-1qBO2LOcNwBSCtE-ZSeylqqGtj1lv6_RjdHzbQqDTTtOgi6hnYLjfnaT7bmzyYU4DpaHyKcb5AmHaON0h2Zu1xOmYye6aRx2fD2mh8Te8cvw44a7eZh7Am6R1F3wGB0NIBFSnbjmO7Tp_wOesydr22d8cXjP2PdPH79dXK6uvn7-cvHhauU0yGnVVM6islhrX6MH0Xnyo1OibruuqsFL2fhWQeUkNpUovZfE2qrVZaO1KK06Y2_2uts0_poxT2YI2WHf24jjnI1ooIa6aXVF6Ot76GacU6Tf_aUoDK0kUWJPuTTmnHBtDt4bAWaJ1WwMrWqWWA1oQ7FSz6uD8twN6I8ddzkS8H4PIFlxGzCZ7MJipg-J_DJ-DA_Kn9_rdn2Iwdn-J-4w_9vCZGnAXC93tZyVqBSAlrX6A8VZyyI</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Ishida, Jun</creator><creator>Toyama, Hirochika</creator><creator>Matsumoto, Ippei</creator><creator>Asari, Sadaki</creator><creator>Goto, Tadahiro</creator><creator>Terai, Sachio</creator><creator>Nanno, Yoshihide</creator><creator>Yamashita, Azusa</creator><creator>Mizumoto, Takuya</creator><creator>Ueda, Yuki</creator><creator>Kido, Masahiro</creator><creator>Ajiki, Tetsuo</creator><creator>Fukumoto, Takumi</creator><creator>Ku, Yonson</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8704-4353</orcidid><orcidid>https://orcid.org/0000-0002-8665-2776</orcidid></search><sort><creationdate>20160701</creationdate><title>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</title><author>Ishida, Jun ; Toyama, Hirochika ; Matsumoto, Ippei ; Asari, Sadaki ; Goto, Tadahiro ; Terai, Sachio ; Nanno, Yoshihide ; Yamashita, Azusa ; Mizumoto, Takuya ; Ueda, Yuki ; Kido, Masahiro ; Ajiki, Tetsuo ; Fukumoto, Takumi ; Ku, Yonson</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-86cae3ae75d7ed01bd390b3179bb670d228d9306c2e8614dd2ae7a695485514a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma, Pancreatic Ductal - epidemiology</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Carcinoma, Pancreatic Ductal - surgery</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Disease</topic><topic>Endocrinology & Metabolism</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Funding</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metachronous</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasms, Second Primary - epidemiology</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Neoplasms, Second Primary - surgery</topic><topic>Pancreas</topic><topic>Pancreas - diagnostic imaging</topic><topic>Pancreas - pathology</topic><topic>Pancreatectomy</topic><topic>Pancreatic ductal carcinoma</topic><topic>Pancreatic Neoplasms - epidemiology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Pathology</topic><topic>Patients</topic><topic>Remnant pancreatic cancer</topic><topic>Second primary</topic><topic>Sensors</topic><topic>Studies</topic><topic>Surgery</topic><topic>Survival Analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishida, Jun</creatorcontrib><creatorcontrib>Toyama, Hirochika</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Asari, Sadaki</creatorcontrib><creatorcontrib>Goto, Tadahiro</creatorcontrib><creatorcontrib>Terai, Sachio</creatorcontrib><creatorcontrib>Nanno, Yoshihide</creatorcontrib><creatorcontrib>Yamashita, Azusa</creatorcontrib><creatorcontrib>Mizumoto, Takuya</creatorcontrib><creatorcontrib>Ueda, Yuki</creatorcontrib><creatorcontrib>Kido, Masahiro</creatorcontrib><creatorcontrib>Ajiki, Tetsuo</creatorcontrib><creatorcontrib>Fukumoto, Takumi</creatorcontrib><creatorcontrib>Ku, Yonson</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishida, Jun</au><au>Toyama, Hirochika</au><au>Matsumoto, Ippei</au><au>Asari, Sadaki</au><au>Goto, Tadahiro</au><au>Terai, Sachio</au><au>Nanno, Yoshihide</au><au>Yamashita, Azusa</au><au>Mizumoto, Takuya</au><au>Ueda, Yuki</au><au>Kido, Masahiro</au><au>Ajiki, Tetsuo</au><au>Fukumoto, Takumi</au><au>Ku, Yonson</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy</atitle><jtitle>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</jtitle><addtitle>Pancreatology</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>16</volume><issue>4</issue><spage>615</spage><epage>620</epage><pages>615-620</pages><issn>1424-3903</issn><eissn>1424-3911</eissn><abstract>Abstract Objectives The aim of this study was to determine the incidence rate and clinical features of second primary pancreatic ductal carcinoma (SPPDC) in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma (PDC). Methods Data of patients undergoing R0 resection for PDC at a single high-volume center were reviewed. SPPDC was defined as a tumor in the remnant pancreas after R0 resection for PDC, and SPPDC met at least one of the following conditions: 1) the time interval between initial pancreatectomy and development of a new tumor was 3 years or more; 2) the new tumor was not located in contact with the pancreatic stump. We investigated the clinical features and treatment outcomes of patients with SPPDC. Results This study included 130 patients who underwent surgical resection for PDC between 2005 and 2014. Six (4.6%) patients developed SPPDC. The cumulative 3- and 5-year incidence rates were 3.1% and 17.7%, respectively. Four patients underwent remnant pancreatectomy for SPPDC. They were diagnosed with the disease in stage IIA or higher and developed recurrence within 6 months after remnant pancreatectomy. One patient received carbon ion radiotherapy and survived 45 months. One patient refused treatment and died 19 months after the diagnosis of SPPDC. Conclusions The incidence rate of SPPDC is not negligible, and the cumulative 5-year incidence rate of SPPDC is markedly high. Post-operative surveillance of the remnant pancreas is critical for the early detection of SPPDC, even in long-term survivors after PDC resection.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>27237099</pmid><doi>10.1016/j.pan.2016.05.003</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-8704-4353</orcidid><orcidid>https://orcid.org/0000-0002-8665-2776</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1424-3903 |
ispartof | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-07, Vol.16 (4), p.615-620 |
issn | 1424-3903 1424-3911 |
language | eng |
recordid | cdi_proquest_miscellaneous_1807078956 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Cancer Cancer therapies Carcinoma, Pancreatic Ductal - epidemiology Carcinoma, Pancreatic Ductal - pathology Carcinoma, Pancreatic Ductal - surgery Cellular biology Chemotherapy Disease Endocrinology & Metabolism Endoscopy Female Funding Gastroenterology and Hepatology Humans Incidence Kaplan-Meier Estimate Lymphatic system Male Medical prognosis Metachronous Metastasis Middle Aged Mutation Neoplasm Recurrence, Local - epidemiology Neoplasms, Second Primary - epidemiology Neoplasms, Second Primary - pathology Neoplasms, Second Primary - surgery Pancreas Pancreas - diagnostic imaging Pancreas - pathology Pancreatectomy Pancreatic ductal carcinoma Pancreatic Neoplasms - epidemiology Pancreatic Neoplasms - pathology Pancreatic Neoplasms - surgery Pathology Patients Remnant pancreatic cancer Second primary Sensors Studies Surgery Survival Analysis Tomography, X-Ray Computed Treatment outcome Tumors |
title | Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T04%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Second%20primary%20pancreatic%20ductal%20carcinoma%20in%20the%20remnant%20pancreas%20after%20pancreatectomy%20for%20pancreatic%20ductal%20carcinoma:%20High%20cumulative%20incidence%20rates%20at%205%20years%20after%20pancreatectomy&rft.jtitle=Pancreatology%20:%20official%20journal%20of%20the%20International%20Association%20of%20Pancreatology%20(IAP)%20...%20%5Bet%20al.%5D&rft.au=Ishida,%20Jun&rft.date=2016-07-01&rft.volume=16&rft.issue=4&rft.spage=615&rft.epage=620&rft.pages=615-620&rft.issn=1424-3903&rft.eissn=1424-3911&rft_id=info:doi/10.1016/j.pan.2016.05.003&rft_dat=%3Cproquest_cross%3E4131151651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1807424532&rft_id=info:pmid/27237099&rft_els_id=1_s2_0_S1424390316300527&rfr_iscdi=true |